PL2648696T3 - Nowa forma podawania racekadotrylu - Google Patents

Nowa forma podawania racekadotrylu

Info

Publication number
PL2648696T3
PL2648696T3 PL11797216T PL11797216T PL2648696T3 PL 2648696 T3 PL2648696 T3 PL 2648696T3 PL 11797216 T PL11797216 T PL 11797216T PL 11797216 T PL11797216 T PL 11797216T PL 2648696 T3 PL2648696 T3 PL 2648696T3
Authority
PL
Poland
Prior art keywords
racecadotril
administration
new form
new
Prior art date
Application number
PL11797216T
Other languages
English (en)
Inventor
Jean-Stéphane Julien
Marc Maury
Jeanne-Marie Lecomte
Xavier Ligneau
Philippe Robert
Jean-Charles Schwartz
Original Assignee
Bioprojet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet filed Critical Bioprojet
Publication of PL2648696T3 publication Critical patent/PL2648696T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL11797216T 2010-12-10 2011-12-09 Nowa forma podawania racekadotrylu PL2648696T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10306397A EP2462922A1 (en) 2010-12-10 2010-12-10 New form of administration of enkephalinase inhibitor
EP11797216.6A EP2648696B1 (en) 2010-12-10 2011-12-09 New form of administration of racecadotril
PCT/EP2011/072315 WO2012076691A1 (en) 2010-12-10 2011-12-09 New form of administration of enkephalinase inhibitor

Publications (1)

Publication Number Publication Date
PL2648696T3 true PL2648696T3 (pl) 2020-07-27

Family

ID=45092498

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11797216T PL2648696T3 (pl) 2010-12-10 2011-12-09 Nowa forma podawania racekadotrylu

Country Status (31)

Country Link
US (1) US9439853B2 (pl)
EP (2) EP2462922A1 (pl)
JP (1) JP5847192B2 (pl)
KR (1) KR101837685B1 (pl)
CN (1) CN103338749B (pl)
AP (1) AP3787A (pl)
AU (1) AU2011340500B2 (pl)
BR (1) BR112013014388A2 (pl)
CA (1) CA2820835C (pl)
CO (1) CO6731092A2 (pl)
CY (1) CY1123056T1 (pl)
DK (1) DK2648696T3 (pl)
EA (1) EA022730B1 (pl)
EC (1) ECSP13012665A (pl)
ES (1) ES2791710T3 (pl)
HR (1) HRP20200555T1 (pl)
HU (1) HUE049273T2 (pl)
IL (1) IL226775A (pl)
LT (1) LT2648696T (pl)
MA (1) MA34724B1 (pl)
ME (1) ME03769B (pl)
MX (1) MX354858B (pl)
NZ (1) NZ611597A (pl)
PL (1) PL2648696T3 (pl)
PT (1) PT2648696T (pl)
RS (1) RS60197B1 (pl)
SG (1) SG191068A1 (pl)
SI (1) SI2648696T1 (pl)
TN (1) TN2013000239A1 (pl)
UA (1) UA111835C2 (pl)
WO (1) WO2012076691A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2987268B1 (fr) * 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
ES2600628T3 (es) * 2012-06-28 2017-02-10 Johnson & Johnson Consumer Inc. Composición líquida de racecadotril
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
CA2876929A1 (en) * 2012-06-28 2014-01-03 Mcneil-Ppc, Inc. Racecadotril lipid compositions
JP2017500355A (ja) * 2013-12-23 2017-01-05 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド ラセカドトリル組成物
MA39009A (fr) 2014-03-10 2015-09-16 Galenicum Health Sl Compositions pharmaceutiques comprenant un agent actif
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
CN105125477A (zh) * 2015-08-19 2015-12-09 黑龙江佰彤儿童药物研究有限公司 一种含消旋卡多曲的药物制剂及制备方法
IT201700099690A1 (it) * 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
CN102151247A (zh) 2000-06-23 2011-08-17 生物计划公司 包含外消旋卡朵曲的干粉制剂
UA80682C2 (en) 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
EP1563848A1 (en) * 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
WO2007102171A2 (en) * 2006-03-07 2007-09-13 Panacea Biotec Ltd Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
TW201014830A (en) 2008-09-30 2010-04-16 Theravance Inc Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

Also Published As

Publication number Publication date
IL226775A (en) 2017-09-28
AP3787A (en) 2016-08-31
CO6731092A2 (es) 2013-08-15
LT2648696T (lt) 2020-05-11
NZ611597A (en) 2015-01-30
BR112013014388A2 (pt) 2016-09-27
CA2820835C (en) 2019-01-08
AP2013006971A0 (en) 2013-07-31
CN103338749A (zh) 2013-10-02
AU2011340500A1 (en) 2013-06-27
CN103338749B (zh) 2017-04-26
HUE049273T2 (hu) 2020-09-28
EA201300688A1 (ru) 2014-11-28
DK2648696T3 (da) 2020-05-04
EP2648696B1 (en) 2020-02-19
JP2014503512A (ja) 2014-02-13
EP2462922A1 (en) 2012-06-13
AU2011340500B2 (en) 2016-10-20
EA022730B1 (ru) 2016-02-29
ES2791710T3 (es) 2020-11-05
WO2012076691A1 (en) 2012-06-14
KR20130124335A (ko) 2013-11-13
UA111835C2 (uk) 2016-06-24
EP2648696A1 (en) 2013-10-16
CA2820835A1 (en) 2012-06-14
MA34724B1 (fr) 2013-12-03
JP5847192B2 (ja) 2016-01-20
SI2648696T1 (sl) 2020-07-31
ECSP13012665A (es) 2013-08-30
KR101837685B1 (ko) 2018-03-12
ME03769B (me) 2021-04-20
CY1123056T1 (el) 2021-10-29
SG191068A1 (en) 2013-07-31
HRP20200555T1 (hr) 2020-07-24
US20130331423A1 (en) 2013-12-12
RS60197B1 (sr) 2020-06-30
MX354858B (es) 2018-03-23
TN2013000239A1 (en) 2014-11-10
US9439853B2 (en) 2016-09-13
MX2013006492A (es) 2013-11-01
PT2648696T (pt) 2020-05-13

Similar Documents

Publication Publication Date Title
PL2648696T3 (pl) Nowa forma podawania racekadotrylu
HK1250647A1 (zh) 苯二氮卓組合物的投與
EP2560484A4 (en) PHARMACEUTICAL COMPOSITION FROM NANOPARTICLES
PL3287131T3 (pl) Terapeutyczne zastosowania ektoiny
EP2637655A4 (en) PHARMACEUTICAL COMPOSITION OF TAXOIDES
EP2552210A4 (en) FORMULAS FROM MAZINDOL
IL224192A (en) Compositions of Vitamin 14 – Epi Analogs d
LT2600881T (lt) Natūralus medicinins junginys
ZA201300083B (en) New drug combinations for the treatment of malaria
PL2654770T3 (pl) Kompozycje farmaceutyczne tenekteplazy
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
EP2543373A4 (en) PHARMACEUTICAL COMPOSITION OF LEVOAMLODIPINE COMPOUND
GB201001203D0 (en) Use of pharmaceutically active compounds
TWM387930U (en) Structure of nozzle
GB201104632D0 (en) Use of medicament
TWM390745U (en) Structure improvement of tea-making can
TWM390349U (en) Structure of door-in-door
TWM386865U (en) Residue-filtering structure of juice-extractor
TWM400763U (en) Improved structure of cold-accumulating cravats
TWM388315U (en) Improved structure of hemoclip
TWM389918U (en) Improved structure of transformer
PL390434A1 (pl) Preparat leczniczy
GB201004479D0 (en) Therapeutic use of new compounds I
TWM389178U (en) Improved structure of caster
HUP1000033D0 (en) Novel compounds with medicinal effect